Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

related to degree

  • Walker, Laura, Ph.D. in Immunology, Scripps Research 2007 - 2011

authors

  • Falkowska, E.
  • Ramos, A.
  • Feng, Yangbo
  • Zhou, T. Q.
  • Moquin, S.
  • Walker, Laura
  • Wu, X.
  • Seaman, M. S.
  • Wrin, T.
  • Kwong, P. D.
  • Wyatt, Richard
  • Mascola, J. R.
  • Poignard, Pascal
  • Burton, Dennis

publication date

  • 2012

journal

  • Journal of Virology  Journal

abstract

  • Recently, several broadly neutralizing monoclonal antibodies (bnMAbs) directed to the CD4-binding site (CD4bs) of gp120 have been isolated from HIV-1-positive donors. These include VRC01, 3BNC117, and NIH45-46, all of which are capable of neutralizing about 90% of circulating HIV-1 isolates and all of which induce conformational changes in the HIV-1 gp120 monomer similar to those induced by the CD4 receptor. In this study, we characterize PGV04 (also known as VRC-PG04), a MAb with potency and breadth that rivals those of the prototypic VRC01 and 3BNC117. When screened on a large panel of viruses, the neutralizing profile of PGV04 was distinct from those of CD4, b12, and VRC01. Furthermore, the ability of PGV04 to neutralize pseudovirus containing single alanine substitutions exhibited a pattern distinct from those of the other CD4bs MAbs. In particular, substitutions D279A, I420A, and I423A were found to abrogate PGV04 neutralization. In contrast to VRC01, PGV04 did not enhance the binding of 17b or X5 to their epitopes (the CD4-induced [CD4i] site) in the coreceptor region on the gp120 monomer. Furthermore, in contrast to CD4, none of the anti-CD4bs MAbs induced the expression of the 17b epitope on cell surface-expressed cleaved Env trimers. We conclude that potent CD4bs bnMAbs can display differences in the way they recognize and access the CD4bs and that mimicry of CD4, as assessed by inducing conformational changes in monomeric gp120 that lead to enhanced exposure of the CD4i site, is not uniquely correlated with effective neutralization at the site of CD4 binding on HIV-1.

subject areas

  • Amino Acid Substitution
  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Antibody Specificity
  • Antigens, CD4
  • Binding Sites, Antibody
  • Glycosylation
  • HIV Envelope Protein gp120
  • Humans
  • Membrane Glycoproteins
  • Models, Molecular
  • Neutralization Tests
  • Protein Binding
  • Protein Conformation
  • Protein Multimerization
scroll to property group menus

Identity

PubMed Central ID

  • PMC3318667

International Standard Serial Number (ISSN)

  • 0022-538X

Digital Object Identifier (DOI)

  • 10.1128/jvi.06973-11

PubMed ID

  • 22345481
scroll to property group menus

Additional Document Info

start page

  • 4394

end page

  • 4403

volume

  • 86

issue

  • 8

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support